Company: Cipla Ltd.

InvaGens Pregabalin Capsules, 25mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg and 300mg is AB-rated generic therapeutic equivalent version of Pfizers Lyrica.
July 22, 2019, 9:38 a.m.

The inspection ended with 7 observations, none of which were a repeat or related to data integrity, the company said on Saturday.
July 22, 2019, 8:40 a.m.

The JV will set up a manufacturing facility of respiratory products; the plant is expected to be commissioned in 2020
July 16, 2019, 11:20 p.m.

Homegrown pharma major Cipla on Tuesday said it has entered into a pact with Jiangsu Acebright Pharmaceutical Co Ltd to form a joint venture in China
July 16, 2019, 1:34 p.m.

As per the agreement, Cipla EU will hold 80% stake and Acebright will hold 20% stake in the JV Co. Cipla EU's investment in the JV Co. is estimated up to $24mn over a period of 4 years.
July 16, 2019, 9:25 a.m.

The EIR received following the inspection carried by the United States Food and Drug Administration (USFDA) at the facility from March 11, 2019, to March 20, 2019.
June 10, 2019, 3:02 p.m.

Shares of Biocon, which dropped 3%, were leading the indexs fall.
June 7, 2019, 12:07 p.m.

Drug firm Cipla said it is looking at continued growth across all its key markets in the current fiscal year and plans to file over 12 abbreviated ne
May 26, 2019, 3:08 p.m.

Total revenue from operations for the last fiscal stood at Rs 16,362.41 crore. It was Rs 15,219.25 crore in the preceding financial year
May 26, 2019, 11:20 a.m.

Post-acquisition, AMP Solar will become an associate of Cipla Limited.
May 24, 2019, 8:24 a.m.